Adynxx Competitors and Similar CompaniesClear all
Adynxx's competitors and similar companies include Olpha and Aerie Pharmaceuticals.
 Adynxx Adynxx is a biopharmaceutical company focused on bringing to market disease-modifying products for the treatment of pain and inflammation. |  Olpha Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products. |  Aerie Pharmaceuticals Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye. | |
Founding Date | Founding Date 2007 | Founding Date 1972 | Founding Date 2005 |
Type | Type Public | Type Private | Type Public |
Tags | |||
Locations | Locations San Francisco, US HQ San Francisco, US | Locations Olaine, LV HQ | Locations Irvine, US HQ Dublin, IE 千代田区, JP Henley On Thames, GB Bedminster, US Durham, US |
Employees | Employees N/A | Employees 2,191 | Employees 3808% increase |
Valuation ($) | Valuation ($) 87.1 k | Valuation ($) N/A | Valuation ($) 722.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) $2.2m (FY, 2018) | Revenue (est.) €122.2m (FY, 2020) | Revenue (est.) $194.1m (FY, 2021) |
Cost of goods | Cost of goods $1.7m (FY, 2018) | Cost of goods €44.5m (FY, 2020) | Cost of goods $26.8m (FY, 2021) |
Gross profit | Gross profit $496k (FY, 2018) | Gross profit €80.1m (FY, 2020) | Gross profit N/A |
Net income | Net income ($8.4m) (FY, 2018) | Net income €9.5m (FY, 2020) | Net income ($74.8m) (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised $ 23.5m | Total funding raised N/A | Total funding raised $ 388.6m |
For sources of this data, please see the company profile
View Company Profiles
Olpha
HQ
Olaine, LV
Employees
2,191
Olpha (formerly known as Olainfarm) is a company engaged in the development and manufacture of pharmaceutical products.
View companyAerie Pharmaceuticals
HQ
Irvine, US
Employees
380↑ 8% increase
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
View company